Searchable abstracts of presentations at key conferences in endocrinology

ea0026p414 | Thyroid (non cancer) | ECE2011

Does levothyroxine plus thyrostatic drug titrated individually offer better control of hyperthyreoidism than thyrostatic alone?

Zmire Josip , Peros Kristijan , Kljajic Kristina , Martinac Kresimir , Colak Boze , Lovrencic Marijana Vucic , Sokolic Lea

In order to compare effects of treatment in hyperthyroid patients treated with thyrostatic drug alone and those treated with thyrostatic plus levothyroxine we reviewed data from 60 consecutive patients attending our outpatient clinic. 27 patients, 25 ♀ and 2 ♂, aged 27–68 years were treated with thyrostatic drug alone, while 33 patients, 31 ♀ and 2 ♂, aged 19–88 years received thyrostatic plus levothyroxine. Number of remissions was greate...

ea0022p817 | Thyroid | ECE2010

Nonthyroidal illness in pregnancy

Zmire Josip , Peros Kristijan , Martinac Kresimir , Colak Boze , Kljajic Kristina , Sokolic Lea

We retrospectively collected data from 62 pregnant females who were followed for hyperthyroidism (n=17), hypothyroidism (n=21), euthyroid Hashimoto’s thyroiditis (n=9), and simple goitre and other non-autoimmune thyroid diseases (n=15).Among them 33 showed at least once during pregnancy low FT4, or low FT3 and FT4 in total on 74 occasions. Low FT4 was found on 15, low FT3 on 15 and low FT<s...

ea0016p736 | Thyroid | ECE2008

Evolution of thyroid autonomy in iodine sufficient environment

Zmire Josip , Martinac Kresimir , Peros Kristijan , Kljajic Kristina , Colak Bozo , Sokolic Lea

Last 10 years, we are living in iodine sufficient environment. To clarify natural course of thyroid autonomy in this conditions, we investigated 100 consecutive patients in last three months – 93 female and 7 male aged 19–86 years. Included were patients with scans showing thyroid autonomy, and patients with nodular or diffuse goiter with low or suppressed TSH. We followed them from their first visit. Thirty patients were hyperthyroid – one spontaneously cured, ...

ea0013oc35 | British Thyroid Association Award | SFEBES2007

A prothrombotic clot structure in hyperthyroidism: A mechanism for increased thrombosis in hyperthyroid individuals?

Ajjan Ramzi , Orme Steve , Standeven Kristina , Phoenix Fladia , Hundia Vikram , Grant Peter

Background: Hyperthyroidism is associated with an increased risk of atherothrombosis and venous thrombotic events by mechanisms that are not fully understood. Previous work has shown that blood clot structure determines the susceptibility to thrombosis and therefore the aim of this study was to investigate the effects of hyperthyroidism on clot structure and fibrinolysis.Methods: Six patients with hyperthyroidism were included in a pilot longitudinal stu...

ea0056gp40 | Adrenal cortex | ECE2018

Long term imaging follow-up of non-functioning adrenal adenomas at Vilnius University Hospital Santaros Klinikos (VUHSK): 2010–2017

Visockiene Zydrune , Svaikeviciene Kristina , Trapikas Julius , Jakubkevicius Valentinas , Kazakeviciute Greta , Anuzyte Joginte

Background: Currently, the European Society of Endocrinology guidelines asserted against additional imaging during follow-up (FUP) in patients with non-functioning adrenal masses <4 cm in size with clear benign features on imaging studies. Our analysed literature data suggests that an increase (minimum 1 cm) in an initially benign adrenal mass during follow-up occurs in 3.5–20% of patients with adrenal incidentalomas.Aim: To analyse the change i...

ea0056gp176 | Parathyroid | ECE2018

Symptom burden and HRQoL reported among patients with chronic hypoparathyroidism: impact of treatment with rhPTH (1-84) and with standard therapy

Chen Kristina , Hadker Nandini , Abibova Irana , Hanbury-Brown Lachlan , Vera-Llonch Montserrat , Clarke Bart

Chronic hypoparathyroidism (HypoPT) is a rare disease associated with a variety of symptoms and diminished health-related quality of life (HRQoL). This study aimed to characterise and quantify the symptom burden, HRQoL, and overall disease impact in patients receiving recombinant human parathyroid hormone (rhPTH1-84, Natpar®) for inadequately controlled HypoPT and in symptomatic patients receiving standard therapy (ST; calcium and/or vitamin D supplements). A w...

ea0073aep35 | Adrenal and Cardiovascular Endocrinology | ECE2021

24-Hour blood pressure profile in patients with adrenal insufficiency

Chifu Irina , Krause Kristina , Zetsche Adrian , Scheuermann Carolin , Burger-Stritt Stephanie , Hahner Stefanie

Introduction Retrospective analyses suggest that patients with adrenal insufficiency (AI) have an increased risk for cardiovascular diseases which was mainly attributed to non-physiological cortisol profiles and/or supraphysiological replacement doses.Material and methodsWe analyzed the 24-hour blood pressure (BP) profiles in patients with primary (PAI) and secondary (SAI) AI. BP threshold criteria for hypert...

ea0075a09 | Adrenal gland | EYES2021

24-Hour blood pressure profile in patients with adrenal insufficiency

Chifu Irina , Krause Kristina , Zetsche Adrian , Scheuermann Carolin , Burger-Stritt Stephanie , Hahner Stefanie

Introduction: Retrospective analyses suggest an increased risk for cardiovascular diseases in patients with adrenal insufficiency (AI), mainly due to supraphysiological replacement doses.Objective: To evaluate the 24-hour blood pressure (BP) profile in patients with primary (PAI) and secondary (SAI) AI.Material and methods: BP threshold criteria for hypertension and dipping status of the 2018 ESC/ESH guidelines were used (24-h: &#8...

ea0092op-07-05 | Oral Session 7: Thyroid hormone receptors | ETA2023

Thyroid hormone action in chronic ischemic heart disease

Dorr Stefanie , Grund Susanne , Sebastian Hones G. , Fuhrer Dagmar , Christian Moller Lars , Lorenz Kristina

Background: Ischemic heart disease (IHD) is one of the leading causes of death worldwide. Thus, there is the necessity to find new therapeutic approaches. Thyroid hormones (TH) have a major impact on cardiac function and even appear to improve the outcome after acute ischemia/reperfusion and in chronic heart failure. Still, TH signaling within the heart is not yet completely understood.Aim: This project aims to investigate the influence of TH receptor al...

ea0093oc40 | Oral communication 6: Thyroid Diseases and Tumors | EYES2023

Thyroid hormone (TH) action in acute and chronic ischemic heart disease

Dorr Stefanie , Grund Susanne , Hones G. Sebastian , Fuhrer Dagmar , Moller Lars Christian , Lorenz Kristina

Ischemic heart disease (IHD) is one of the leading causes of death worldwide. TH have impact on cardiac function and even appear to improve outcome after acute ischemia/reperfusion and in chronic heart failure. This project aims to investigate the influence of TH receptor alpha (TRα) on IHD using specific mouse models to assess the contribution of canonical vs. non-canonical TH signaling. Mice underwent permanent ligation of the left descending coronary artery and were tr...